I didn’t think I’d be writing about Stanislaw Burzynski again so soon, but to my surprise a very good article in Newsweek describing cancer quack Stanislaw Burzynski popped up in my Google Alerts yesterday. I hadn’t expected much in the way of news coverage about Burzynski for several months, given that the second half of […]
The other day, I suddenly realized that it’s been a long time since I’ve written about the Polish expat doctor in Houston who treats patients with advanced brain cancer with a concoction that he dubbed antineoplastons (ANPs). I’m referring, of course, to Stanislaw Burzynski who, despite the fact that he has no training in medical […]
NOTE: Orac is on vacation recharging his Tarial cells and interacting with ion channel scientists, as a good computer should. In the meantime, he is rerunning oldies but goodies, classics, even. (OK, let’s not get carried away.) Here’s one from all the way back in 2007. Notice how, the more things change, the more they […]
The approval of new drugs and medical devices is a process fraught with scientific, political, and ethical landmines. Inherent in any such process is an unavoidable conflict between rigorous science and safety on the one side, which tend to slow the process down by requiring large randomized clinical trials that can take years, versus forces […]
When I wrote yesterday about the cruel sham that is “right-to-try,” , one criticism (among many) that I made of these misguided, profoundly patient-unfriendly laws was that I have as yet been unable to find a single example of a patient who has managed to obtain access to an experimental therapeutic through such a law, […]
